Primarily by activating AMPK and its downstream signaling in liver, SCH has pleiotropic effects which are beneficial for attenuating hepatic steatosis covering glucose metabolism, adipogenesis, etc. Moreover, immunofluorescence images demonstrated facilitated glucose utilization and potentiated insulin sensitivity by SCH in the FFA-induced hepatic steatosis model. Here, INS is linked to fatty liver disease.